Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-03-01 @ 9:58 AM
Study NCT ID:
NCT05082493
Status:
WITHDRAWN
Last Update Posted:
2024-06-06
First Post:
2021-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas
Sponsor:
WPD Pharmaceuticals Sp. z o.o.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-12-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-22
First Submit QC Date:
None
Study First Post Date:
2021-10-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-03
Last Update Post Date:
2024-06-06
Last Update Post Date Type:
ACTUAL